301301 川宁生物
已收盘 11-18 15:00:00
资讯
新帖
简况
山西证券：给予川宁生物增持评级
证券之星 · 11-12
山西证券：给予川宁生物增持评级
业绩亮眼！川宁生物前三季度净利润超10亿元 同比大增68.07%
中国财富通 · 10-29
业绩亮眼！川宁生物前三季度净利润超10亿元 同比大增68.07%
A股化学制药板块强势拉升，科源制药20cm涨停，无锡晶海涨超10%，川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。
美港电讯 · 10-24
A股化学制药板块强势拉升，科源制药20cm涨停，无锡晶海涨超10%，川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。
华鑫证券：给予川宁生物买入评级
证券之星 · 10-23
华鑫证券：给予川宁生物买入评级
川宁生物（301301）2024年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 10-23
川宁生物（301301）2024年三季报简析：营收净利润同比双双增长，盈利能力上升
川宁生物：10月22日接受机构调研，国盛证券、中信建投等多家机构参与
证券之星 · 10-22
川宁生物：10月22日接受机构调研，国盛证券、中信建投等多家机构参与
川宁生物(301301)9月30日股东户数4.32万户，较上期减少12.16%
证券之星 · 10-22
川宁生物(301301)9月30日股东户数4.32万户，较上期减少12.16%
10月22日川宁生物现1笔大宗交易 机构净买入3969万元
证券之星 · 10-22
10月22日川宁生物现1笔大宗交易 机构净买入3969万元
民生证券：给予川宁生物买入评级
证券之星 · 10-22
民生证券：给予川宁生物买入评级
图解川宁生物三季报：第三季度单季净利润同比增24.20%
证券之星 · 10-22
图解川宁生物三季报：第三季度单季净利润同比增24.20%
川宁生物(301301.SZ)发布前三季度业绩，净利润10.76亿元，增长68.07%
智通财经 · 10-21
川宁生物(301301.SZ)发布前三季度业绩，净利润10.76亿元，增长68.07%
川宁生物最新公告：前三季度净利润10.76亿元 同比增长68.07%
证券之星 · 10-21
川宁生物最新公告：前三季度净利润10.76亿元 同比增长68.07%
10月21日川宁生物涨13.56%，申万菱信中证1000指数增强A基金重仓该股
证券之星 · 10-21
10月21日川宁生物涨13.56%，申万菱信中证1000指数增强A基金重仓该股
10月18日川宁生物涨5.77%，申万菱信中证1000指数增强A基金重仓该股
证券之星 · 10-18
10月18日川宁生物涨5.77%，申万菱信中证1000指数增强A基金重仓该股
10月16日川宁生物现1笔大宗交易 机构净买入5925万元
证券之星 · 10-16
10月16日川宁生物现1笔大宗交易 机构净买入5925万元
川宁生物10月16日现1笔大宗交易 成交金额5925万元
新浪证券-红岸工作室 · 10-16
川宁生物10月16日现1笔大宗交易 成交金额5925万元
川宁生物10月14日现1笔大宗交易 成交金额6095万元
新浪证券-红岸工作室 · 10-14
川宁生物10月14日现1笔大宗交易 成交金额6095万元
10月14日川宁生物现1笔大宗交易 机构净买入6095万元
证券之星 · 10-14
10月14日川宁生物现1笔大宗交易 机构净买入6095万元
10月11日川宁生物跌5.59%，申万菱信中证1000指数增强A基金重仓该股
证券之星 · 10-11
10月11日川宁生物跌5.59%，申万菱信中证1000指数增强A基金重仓该股
10月8日川宁生物涨10.62%，申万菱信中证1000指数增强A基金重仓该股
证券之星 · 10-08
10月8日川宁生物涨10.62%，申万菱信中证1000指数增强A基金重仓该股
公司概况
公司名称：
伊犁川宁生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-12-27
主营业务：
伊犁川宁生物技术股份有限公司的主营业务为生物发酵技术的研发和产业化。公司的主要产品是硫氰酸红霉素、6-APA、青霉素G钾盐、头孢类（中间体）、熊去氧胆酸粗品、辅酶Q10菌丝体、红没药醇、5-羟基色氨酸、麦角硫因、依克多因、肌醇、角鲨烷、PHA聚羟基脂肪酸酯。公司2024年2月成功申报“新疆维吾尔自治区重点研发计划项目”、2024年6月荣获“自治区科学技术进步一等奖”。
发行价格：
5.00
{"stockData":{"symbol":"301301","market":"SZ","secType":"STK","nameCN":"川宁生物","latestPrice":13.26,"timestamp":1731913437000,"preClose":13.67,"halted":0,"volume":32506600,"delay":0,"floatShares":616000000,"shares":2227000000,"eps":0.618,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.41,"latestTime":"11-18 15:00:00","open":13.67,"high":13.77,"low":13.15,"amount":434000000,"amplitude":0.0454,"askPrice":13.27,"askSize":2294,"bidPrice":13.26,"bidSize":674,"shortable":0,"etf":0,"ttmEps":0.618,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"adjPreClose":13.67,"symbolType":"stock","openAndCloseTimeList":[[1731893400000,1731900600000],[1731906000000,1731913200000]],"highLimit":15.04,"lowLimit":12.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2227160000,"pbRate":4.02,"roa":"--","roe":"14.75%","epsLYR":0.42,"committee":-0.345879,"marketValue":29532000000,"floatMarketCap":8167000000,"peRate":21.456312,"changeRate":-0.03,"turnoverRate":0.0528,"status":1},"requestUrl":"/m/hq/s/301301/wiki","defaultTab":"wiki","newsList":[{"id":"2482727735","title":"山西证券：给予川宁生物增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482727735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482727735?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:47","pubTimestamp":1731401247,"startTime":"0","endTime":"0","summary":"山西证券股份有限公司魏赟近期对川宁生物进行研究并发布了研究报告《前三季度业绩超预期，高值、大宗合成生物学品种打开成长空间》，本报告对川宁生物给出增持评级，当前股价为15.38元。 川宁生物 事件描述 前三季度业绩超预期，营收与净利润高速增长。 红没药醇等高值品种生产销售，PHA等大宗合成生物学品种陆续落地。预计全年业绩超预期，上调2024-2026年盈利预测，持续覆盖，给予“增持-B”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200026836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","002500"],"gpt_icon":0},{"id":"2479422141","title":"业绩亮眼！川宁生物前三季度净利润超10亿元 同比大增68.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479422141","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479422141?lang=zh_cn&edition=full","pubTime":"2024-10-29 16:44","pubTimestamp":1730191466,"startTime":"0","endTime":"0","summary":"10月22日，川宁生物披露的2024年三季度报告显示，前三季度实现营业收入44.56亿元，同比增长24.43%；实现归母净利润10.76亿元，同比增长68.07%。而前三季度业绩增长的另一原因，则是公司工艺技术的不断提升，有效降低了生产成本，从而使得本期净利润同比上升。公开资料显示，川宁生物作为一家抗生素中间体公司，受生产成本影响较大。这是川宁生物自上市以来，首次获得“A”级信息披露考核评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=Z3bJ%2B3aLe3c%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301301"],"gpt_icon":0},{"id":"2477651489","title":"A股化学制药板块强势拉升，科源制药20cm涨停，无锡晶海涨超10%，川宁生物、尔康制药、振东制药赛托生物、海辰药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2477651489","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477651489?lang=zh_cn&edition=full","pubTime":"2024-10-24 09:32","pubTimestamp":1729733526,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","159982","301281","301301","BK0028","300583","01477","BK0060","BK0077","BK1574","BK0186","BK1191","300584","399300","300158","300267"],"gpt_icon":0},{"id":"2477150347","title":"华鑫证券：给予川宁生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477150347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477150347?lang=zh_cn&edition=full","pubTime":"2024-10-23 11:51","pubTimestamp":1729655483,"startTime":"0","endTime":"0","summary":"华鑫证券胡博新近期对川宁生物进行研究并发布了研究报告《公司事件点评报告：持续降本增效，合成生物学产品拓展成长空间》，本报告对川宁生物给出买入评级，当前股价为13.23元。 出口需求拉动，供给相对稳定 2024年前3季度公司收入同比增长24.43%，主要系青霉素中间体、硫氰酸红霉素和头孢类中间体均保持销量增长。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为12.73。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300017470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301301"],"gpt_icon":0},{"id":"2477392488","title":"川宁生物（301301）2024年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2477392488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477392488?lang=zh_cn&edition=full","pubTime":"2024-10-23 06:06","pubTimestamp":1729634809,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期川宁生物发布2024年三季报。截至本报告期末，公司营业总收入44.56亿元，同比上升24.43%，归母净利润10.76亿元，同比上升68.07%。按单季度数据看，第三季度营业总收入12.61亿元，同比上升8.31%，第三季度归母净利润3.1亿元，同比上升24.2%。本报告期川宁生物盈利能力上升，毛利率同比增幅13.73%，净利率同比增幅111.45%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102300004731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301"],"gpt_icon":0},{"id":"2477387337","title":"川宁生物：10月22日接受机构调研，国盛证券、中信建投等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2477387337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477387337?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:42","pubTimestamp":1729604524,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月22日川宁生物发布公告称公司于2024年10月22日接受机构调研，国盛证券、中信建投、开源证券、国投证券、德邦证券、国金证券、方正证券、中融汇信投资有限公司、红杉PIPE、野村证券、浙商证券、东吴证券、凯联资本、阳光资产、银河证券、申万宏源、民生证券、太平洋证券、东方证券、山西证券、中信证券参与。该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为12.73。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200036652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","301301","601066","161027","BK0239"],"gpt_icon":0},{"id":"2477800339","title":"川宁生物(301301)9月30日股东户数4.32万户，较上期减少12.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477800339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477800339?lang=zh_cn&edition=full","pubTime":"2024-10-22 17:07","pubTimestamp":1729588044,"startTime":"0","endTime":"0","summary":"证券之星消息，近日川宁生物披露，截至2024年9月30日公司股东户数为4.32万户，较6月30日减少5975.0户，减幅为12.16%。在化学制药行业个股中，川宁生物股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.17万户。从股价来看，2024年6月30日至2024年9月30日，川宁生物区间涨幅为6.81%，在此期间股东户数减少5975.0户，减幅为12.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200028235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2477802753","title":"10月22日川宁生物现1笔大宗交易 机构净买入3969万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477802753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477802753?lang=zh_cn&edition=full","pubTime":"2024-10-22 16:48","pubTimestamp":1729586936,"startTime":"0","endTime":"0","summary":"证券之星消息，10月22日川宁生物发生大宗交易，交易数据如下：大宗交易成交价格13.23元，相对当日收盘价折价1.49%，成交300万股，成交金额3969万元，买方营业部为机构专用，卖方营业部为东方证券股份有限公司上海浦东新区唐安路证券营业部。近三个月该股共发生5笔大宗交易，合计成交21.0万手，折价成交5笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200025743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2477977876","title":"民生证券：给予川宁生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2477977876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477977876?lang=zh_cn&edition=full","pubTime":"2024-10-22 13:05","pubTimestamp":1729573523,"startTime":"0","endTime":"0","summary":"民生证券股份有限公司王班近期对川宁生物进行研究并发布了研究报告《2024年三季度报告点评：利润实现中高速增长，毛利率水平持续向上优化》，本报告对川宁生物给出买入评级，当前股价为13.59元。截至2024年8月底，红没药醇和5-羟基色氨酸已经量产，麦角硫因预计在今年亦能投入生产。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为12.73。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200016939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301301"],"gpt_icon":0},{"id":"2477789957","title":"图解川宁生物三季报：第三季度单季净利润同比增24.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477789957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477789957?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:33","pubTimestamp":1729528419,"startTime":"0","endTime":"0","summary":"证券之星消息，川宁生物2024年三季报显示，公司主营收入44.56亿元，同比上升24.43%；归母净利润10.76亿元，同比上升68.07%；扣非净利润10.75亿元，同比上升68.15%；其中2024年第三季度，公司单季度主营收入12.61亿元，同比上升8.31%；单季度归母净利润3.1亿元，同比上升24.2%；单季度扣非净利润3.09亿元，同比上升25.4%；负债率28.07%，投资收益-715.85万元，财务费用4246.33万元，毛利率35.82%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200000150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301"],"gpt_icon":0},{"id":"2477830909","title":"川宁生物(301301.SZ)发布前三季度业绩，净利润10.76亿元，增长68.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477830909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477830909?lang=zh_cn&edition=full","pubTime":"2024-10-21 18:32","pubTimestamp":1729506772,"startTime":"0","endTime":"0","summary":"智通财经APP讯，川宁生物(301301.SZ)发布2024年三季度报告，该公司前三季度营业收入为44.56亿元，同比增长24.43%。归属于上市公司股东的净利润为10.76亿元，同比增长68.07%。归属于上市公司股东的扣除非经常性损益的净利润为10.75亿元，同比增长68.15%。基本每股收益为0.48元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301301"],"gpt_icon":0},{"id":"2477830974","title":"川宁生物最新公告：前三季度净利润10.76亿元 同比增长68.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477830974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477830974?lang=zh_cn&edition=full","pubTime":"2024-10-21 18:30","pubTimestamp":1729506601,"startTime":"0","endTime":"0","summary":"川宁生物发布2024年第三季度报告，前三季度实现营业收入44.56亿元，同比增长24.43%；净利润10.76亿元，同比增长68.07%；基本每股收益0.48元，同比增长65.52%。第三季度实现营业收入12.61亿元，同比增长8.31%；净利润3.09亿元，同比增长24.20%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100024294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301"],"gpt_icon":0},{"id":"2477833851","title":"10月21日川宁生物涨13.56%，申万菱信中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2477833851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477833851?lang=zh_cn&edition=full","pubTime":"2024-10-21 16:23","pubTimestamp":1729499014,"startTime":"0","endTime":"0","summary":"证券之星消息，10月21日川宁生物涨13.56%，收盘报14.57元，换手率15.08%，成交量92.86万手，成交额12.79亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为申万菱信中证1000指数增强A。申万菱信中证1000指数增强A目前规模为2.98亿元，最新净值0.9099，较上一交易日上涨4.23%，近一年上涨4.78%。申万菱信中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100019104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399852","BK0239","000852.SH","000001.SH","159845","301301"],"gpt_icon":0},{"id":"2476408549","title":"10月18日川宁生物涨5.77%，申万菱信中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476408549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476408549?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:36","pubTimestamp":1729240608,"startTime":"0","endTime":"0","summary":"证券之星消息，10月18日川宁生物涨5.77%，收盘报12.83元，换手率8.96%，成交量55.18万手，成交额6.94亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为申万菱信中证1000指数增强A。申万菱信中证1000指数增强A目前规模为2.98亿元，最新净值0.873，较上一交易日下跌0.4%，近一年下跌1.4%。申万菱信中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800026557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","000001.SH","159845","000852.SH","399852","BK0239"],"gpt_icon":0},{"id":"2475812937","title":"10月16日川宁生物现1笔大宗交易 机构净买入5925万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475812937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475812937?lang=zh_cn&edition=full","pubTime":"2024-10-16 16:43","pubTimestamp":1729068211,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日川宁生物发生大宗交易，交易数据如下：大宗交易成交价格11.85元，相对当日收盘价折价1.5%，成交500万股，成交金额5925万元，买方营业部为机构专用，卖方营业部为东方证券股份有限公司上海浦东新区唐安路证券营业部。近三个月该股共发生3笔大宗交易，合计成交15.0万手，折价成交3笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600025703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2475376389","title":"川宁生物10月16日现1笔大宗交易 成交金额5925万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475376389","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475376389?lang=zh_cn&edition=full","pubTime":"2024-10-16 16:40","pubTimestamp":1729068000,"startTime":"0","endTime":"0","summary":" 10月16日，川宁生物收跌0.25%，收盘价为12.03元，发生1笔大宗交易，合计成交量500万股，成交金额5925万元。 第1笔成交价格为11.85元，成交500.00万股，成交金额5,925.00万元，溢价率为-1.50%，买方营业部为机构专用，卖方营业部为东方证券股份有限公司上海浦东新区唐安路证券营业部。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为1.8亿元。该股近5个交易日累计下跌8.31%，主力资金合计净流出1.66亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-10-16/doc-incsttpc6988456.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-10-16/doc-incsttpc6988456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2475358452","title":"川宁生物10月14日现1笔大宗交易 成交金额6095万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475358452","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475358452?lang=zh_cn&edition=full","pubTime":"2024-10-14 17:01","pubTimestamp":1728896460,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 第1笔成交价格为12.19元，成交500.00万股，成交金额6,095.00万元，溢价率为-1.53%，买方营业部为机构专用，卖方营业部为东方证券股份有限公司上海浦东新区唐安路证券营业部。 进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为6095万元。该股近5个交易日累计下跌9.30%，主力资金合计净流出3.43亿元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-10-14/doc-incspfhy8241497.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-10-14/doc-incspfhy8241497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2475233061","title":"10月14日川宁生物现1笔大宗交易 机构净买入6095万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475233061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475233061?lang=zh_cn&edition=full","pubTime":"2024-10-14 16:52","pubTimestamp":1728895946,"startTime":"0","endTime":"0","summary":"证券之星消息，10月14日川宁生物发生大宗交易，交易数据如下：大宗交易成交价格12.19元，相对当日收盘价折价1.53%，成交500万股，成交金额6095万元，买方营业部为机构专用，卖方营业部为东方证券股份有限公司上海浦东新区唐安路证券营业部。近三个月该股共发生1笔大宗交易，合计成交5.0万手，折价成交1笔。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101400020593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2474057508","title":"10月11日川宁生物跌5.59%，申万菱信中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474057508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474057508?lang=zh_cn&edition=full","pubTime":"2024-10-11 16:41","pubTimestamp":1728636089,"startTime":"0","endTime":"0","summary":"证券之星消息，10月11日川宁生物跌5.59%，收盘报12.0元，换手率6.51%，成交量40.11万手，成交额4.91亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为申万菱信中证1000指数增强A。申万菱信中证1000指数增强A目前规模为2.98亿元，最新净值0.9018，较上一交易日下跌0.69%，近一年上涨0.82%。申万菱信中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100024338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159845","399852","000852.SH","BK0239","000001.SH","301301"],"gpt_icon":0},{"id":"2473144130","title":"10月8日川宁生物涨10.62%，申万菱信中证1000指数增强A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473144130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473144130?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:56","pubTimestamp":1728381384,"startTime":"0","endTime":"0","summary":"证券之星消息，10月8日川宁生物涨10.62%，收盘报15.1元，换手率12.84%，成交量79.07万手，成交额11.84亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为申万菱信中证1000指数增强A。申万菱信中证1000指数增强A目前规模为2.98亿元，最新净值0.909，较上一交易日上涨10.48%，近一年上涨0.46%。申万菱信中证1000指数增强A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800027182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399852","000852.SH","301301","000001.SH","BK0239","159845"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-12-27","address":"新疆维吾尔自治区伊犁哈萨克自治州霍尔果斯市霍尔果斯经济开发区伊宁园区拱宸路1号","stockEarnings":[{"period":"1week","weight":-0.1473},{"period":"1month","weight":0.0335},{"period":"3month","weight":0.1946},{"period":"6month","weight":-0.0949},{"period":"1year","weight":0.4533},{"period":"ytd","weight":0.602}],"companyName":"伊犁川宁生物技术股份有限公司","boardCode":"AI0027","perCapita":"14269股","boardName":"医药制造业","registeredCapital":"222716万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 伊犁川宁生物技术股份有限公司的主营业务为生物发酵技术的研发和产业化。公司的主要产品是硫氰酸红霉素、6-APA、青霉素G钾盐、头孢类（中间体）、熊去氧胆酸粗品、辅酶Q10菌丝体、红没药醇、5-羟基色氨酸、麦角硫因、依克多因、肌醇、角鲨烷、PHA聚羟基脂肪酸酯。公司2024年2月成功申报“新疆维吾尔自治区重点研发计划项目”、2024年6月荣获“自治区科学技术进步一等奖”。","serverTime":1731972337666,"listedPrice":5,"stockholders":"43161人(较上一季度减少12.16%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"川宁生物(301301)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供川宁生物(301301)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"川宁生物,301301,川宁生物股票,川宁生物股票老虎,川宁生物股票老虎国际,川宁生物行情,川宁生物股票行情,川宁生物股价,川宁生物股市,川宁生物股票价格,川宁生物股票交易,川宁生物股票购买,川宁生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"川宁生物(301301)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供川宁生物(301301)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}